x min read

News In Reviews- Xilinx Inc. (NASDAQ:XLNX), TrueCar, Inc. (NASDAQ:TRUE), Isis Pharmaceuticals, Inc. (NASDAQ:ISIS),

News In Reviews- Xilinx Inc. (NASDAQ:XLNX), TrueCar, Inc. (NASDAQ:TRUE), Isis Pharmaceuticals, Inc. (NASDAQ:ISIS),
Written by
Ryan Mitchell
Published on
November 13, 2014
Copy URL
Share on LinkedIn
Share on Reddit
Share on Twitter/X
Share on Facebook
InsidrFinancial

Xilinx Inc. (NASDAQ:XLNX) Trend Analysis released that the industry's first low latency 25G Ethernet IP for FPGAs to address throughput challenges in data center applications. The low latency 25G Ethernet MAC as well as PCS LogiCORE IP solution assists to cut data center CapEx by providing a migration path from 10G to 25G links and delivers a drastic increase in performance by more than doubling the front panel bandwidth between top of rack switches and servers. Xilinx Inc. (NASDAQ:XLNX) has the market capitalization of 11.467 Billion. Shares of firm moved down -0.09% to close at $43.36 with the total traded volume of 1.7 Million. The firm has current ratio of 3.40 for the most recent quarter.As a division of this offering, Scott Painter, TrueCar, Inc. (NASDAQ:TRUE) Trend Analysis and CEO, has indicated an interest in purchasing up to 29,411 shares of common stock at the public offering price for an aggregate purchase price of up to ~$500K. TrueCar, Inc. (NASDAQ:TRUE) begun last trade with a price of $17.51 and throughout the trading session climbed at a high of $17.72. The day-trade ended with -0.34% to $17.43. The stock is going forward to its 52 week low with 92.60% and lagging behind from its 52 week high price with -30.28%. TRUE last month stock price volatility remained 7.83%.Isis Pharmaceuticals, Inc. (NASDAQ:ISIS) Trend Analysis declared that the pricing of its offering of $425M aggregate principal amount of Convertible Senior Notes due 2021 in a private placement. Isis anticipates that the net proceeds from this proposing will be around $413.9M. All of the net proceeds of the offering will be applied toward the repurchase of Isis' 2 % Convertible Senior Notes due 2019 Isis Pharmaceuticals, Inc. (NASDAQ:ISIS) stock price closed at $51.08 with the total traded volume of 5.6 Million shares. Its price to sales ratio ended at 39.80. Its market capitalization is 6.035 Billion. The stock owned by the Financial Institutions was 89.50% while by insiders was 0.10%.

Discover Hidden Gems

Don't miss the next big opportunity. Subscribe for timely alerts on potential market movers.

Recommended for You